van der Hilst JC - Search Results

1

Beneficial response to interleukin 1 receptor antagonist in traps.

Simon A, Bodar EJ, van der Hilst JC, van der Meer JW, Fiselier TJ, Cuppen MP, Drenth JP. Simon A, et al. Among authors: van der hilst jc, van der meer jw. Am J Med. 2004 Aug 1;117(3):208-10. doi: 10.1016/j.amjmed.2004.02.039. Am J Med. 2004. PMID: 15300976 No abstract available.

2

Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.

van der Hilst JCH, Bodar EJ, Barron KS, Frenkel J, Drenth JPH, van der Meer JWM, Simon A; International HIDS Study Group. van der Hilst JCH, et al. Medicine (Baltimore). 2008 Nov;87(6):301-310. doi: 10.1097/MD.0b013e318190cfb7. Medicine (Baltimore). 2008. PMID: 19011501 Free article.

3

Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model.

Bodar EJ, van der Hilst JC, Drenth JP, van der Meer JW, Simon A. Bodar EJ, et al. Among authors: van der hilst jc, van der meer jw. Neth J Med. 2005 Jul-Aug;63(7):260-4. Neth J Med. 2005. PMID: 16093577 Free article.

4

Beneficial response to anakinra and thalidomide in Schnitzler's syndrome.

de Koning HD, Bodar EJ, Simon A, van der Hilst JC, Netea MG, van der Meer JW. de Koning HD, et al. Among authors: van der hilst jc, van der meer jw. Ann Rheum Dis. 2006 Apr;65(4):542-4. doi: 10.1136/ard.2005.045245. Epub 2005 Aug 11. Ann Rheum Dis. 2006. PMID: 16096327 Free PMC article.

5

Hereditary periodic fever and reactive amyloidosis.

van der Hilst JC, Simon A, Drenth JP. van der Hilst JC, et al. Clin Exp Med. 2005 Oct;5(3):87-98. doi: 10.1007/s10238-005-0071-6. Clin Exp Med. 2005. PMID: 16284730 Review.

6

Two patients with recurrent fever and wine red discolouration of the eyelids.

Bodar EJ, Simon A, van der Hilst JC, van Deuren M. Bodar EJ, et al. Among authors: van der hilst jc, van deuren m. Neth J Med. 2004 Apr;62(4):119-20, 139. Neth J Med. 2004. PMID: 15255081 Free article. No abstract available.

7

Molecular mechanisms of amyloidosis.

van der Hilst JC, Simon A, Drenth JP. van der Hilst JC, et al. N Engl J Med. 2003 Nov 6;349(19):1872-3; author reply 1872-3. N Engl J Med. 2003. PMID: 14606469 No abstract available.

8

Defective apoptosis of peripheral-blood lymphocytes in hyper-IgD and periodic fever syndrome.

Bodar EJ, van der Hilst JC, van Heerde W, van der Meer JW, Drenth JP, Simon A. Bodar EJ, et al. Among authors: van der hilst jc, van heerde w, van der meer jw. Blood. 2007 Mar 15;109(6):2416-8. doi: 10.1182/blood-2005-10-039578. Epub 2006 Nov 30. Blood. 2007. PMID: 17138829 Free article.

9

Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome.

van der Hilst JC, Drenth JP, Bodar EJ, Bijzet J, van der Meer JW, Simon A; International HIDS Study Group. van der Hilst JC, et al. Among authors: van der meer jw. Amyloid. 2005 Jun;12(2):115-9. doi: 10.1080/13506120500106982. Amyloid. 2005. PMID: 16011988

10

Lovastatin inhibits formation of AA amyloid.

van der Hilst JC, Kluve-Beckerman B, Bodar EJ, van der Meer JW, Drenth JP, Simon A. van der Hilst JC, et al. Among authors: van der meer jw. J Leukoc Biol. 2008 May;83(5):1295-9. doi: 10.1189/jlb.1107723. Epub 2008 Feb 19. J Leukoc Biol. 2008. PMID: 18285405

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page